Skip to content

A clinical trial to study the effects of a drug - tranexamic acid given through vapour form or injection form to patients coming to emergencycoughing out blood.

Nebulized vs Intravenous tranexamic acid in patients with hemoptysis presenting to Emergency Department : A randomized control study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019337
Enrollment
50
Registered
2019-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J470- Bronchiectasis with acute lower respiratory infection

Interventions

Intervention1: Nebulised tranexamic acid arm: Nebulised arm would receive 500mg(5ml) of nebulized TA mixed with 5 ml of distilled water stat followed by 500mg TA nebulised TDS . The osmolarity of TA i

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult( >18years) patients presenting to the Emergency Department with active hemoptysis.

Exclusion criteria

Exclusion criteria: 1) Patients already received tranexamic acid before presenting to the hospital. 2) Intubated patients on mechanical ventilation. 3) Patients with massive life-threatening hemoptysis who need to be immediately shifted for interventional procedures.

Design outcomes

Primary

MeasureTime frame
Cessation of bleeding in patients presenting to ED with active hemoptysis at 30 minutes after initiation of treatment.Timepoint: 30 minutes after initiation of treatment.

Secondary

MeasureTime frame
1. Need for urgent interventional procedures â?? Bronchoscopy and bronchial artery embolization(BAE).Timepoint: Time of interventional procedure;2. Reduction in volume of hemoptysis at 6, 12 and 24 hours after presenting to Emergency department(ED).Timepoint: 6,12 and 24 hours

Countries

India

Contacts

Public ContactPraveen Aggarwal

AIIMS, New Delhi

peekay_124@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026